Association between oral JAK-1 inhibitors and infection risks in atopic dermatitis: a retrospective analysis of the FAERS database

BackgroundJanus kinase (JAK)-1 inhibitors have been approved for moderate-to-severe atopic dermatitis (AD). Despite favorable efficacy, their real-world infection risk profile requires further investigation.MethodsWe conducted a retrospective disproportionality analysis using the U.S. Food and Drug...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Zenan Tang, Zhanglei Mu, Xiaojie Wang, Yan Zhao
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2025-11-01
Σειρά:	Frontiers in Medicine
Θέματα:	Janus kinase inhibitors atopic dermatitis adverse events FAERS database infection
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1694688/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!